Dr. Rashid A Awan M.D.
Hematologist-Oncologist | Hematology & Oncology
337 Somerset St Johnstown PA, 15901About
Dr. Rashid Awan is a hematologist oncologist practicing in Johnstown, PA. Dr. Awan specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ Auto De Ciudad Juarez, Esc De Med, Ciudad Juarez, Chihuahua 1981
College of Human Medicine Benha University 1981
University of Cuidad
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Treatments
- Melanoma
- Anemia
- Breast Cancer
- Lung Cancer
- Anal Cancer
- Colon Cancer
- Lymphoma
- Ovarian Cancer
- Immunodeficiency
- Leukemia
- Testicular Cancer
- AerolaseĀ® Technologies
- Extra Corporeal Shockwave Therapy
Dr. Rashid A Awan M.D.'s Practice location
Johnstown, PA 15901Get Direction
Dr. Rashid A Awan M.D.'s reviews
Write ReviewPatient Experience with Dr. Awan
Recommended Articles
- Schools Join the Fight Against Lymphoma and Blood Cancers
Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Multiple Myeloma: What is Autotransplantation?
During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
Nearby Providers
- Dr. Michael D Voloshin M.D.337 Somerset St Johnstown PA 15901